Glassman Wealth Services’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-35
| Closed | – | – | 1806 |
|
|
2022
Q2 | $0 | Buy |
+35
| New | – | ﹤0.01% | 1814 |
|
|
2021
Q4 | – | Sell |
-162
| Closed | -$2K | – | 1752 |
|
|
2021
Q3 | $2K | Hold |
162
| – | – | ﹤0.01% | 1174 |
|
|
2021
Q2 | $3K | Hold |
162
| – | – | ﹤0.01% | 1058 |
|
|
2021
Q1 | $3K | Hold |
162
| – | – | ﹤0.01% | 997 |
|
|
2020
Q4 | $3K | Hold |
162
| – | – | ﹤0.01% | 978 |
|
|
2020
Q3 | $2K | Hold |
162
| – | – | ﹤0.01% | 999 |
|
|
2020
Q2 | $2K | Hold |
162
| – | – | ﹤0.01% | 861 |
|
|
2020
Q1 | $2K | Sell |
162
-1,000
| -86% | -$12.3K | ﹤0.01% | 709 |
|
|
2019
Q4 | $27K | Buy |
1,162
+1,000
| +617% | +$23.2K | 0.01% | 335 |
|
|
2019
Q3 | $3K | Sell |
162
-20
| -11% | -$370 | ﹤0.01% | 625 |
|
|
2019
Q2 | $3K | Buy |
182
+20
| +12% | +$330 | ﹤0.01% | 642 |
|
|
2019
Q1 | $4K | Hold |
162
| – | – | ﹤0.01% | 581 |
|
|
2018
Q4 | $4K | Buy |
+162
| New | +$4K | ﹤0.01% | 459 |
|